From screening to care: a longitudinal implementation evaluation of a community-based hepatitis B program Authors: Chul S. Hyun, Sara Soonsik Kim Published: 2026 ABSTRACT BackgroundCommunity-based hepatitis B virus (HBV) screening programs are widely used to identify chronic infection in high-risk immigrant populations in the United States. However, screening alone does not ensure engagement in care, and the processes that determine progression from diagnosis to sustained clinical management remain poorly characterized. In particular, there is limited longitudinal evidence evaluating real-world implementation across the full HBV care continuum.MethodsWe conducted a RE-AIM–based implementation evaluation of a longstanding community-based HBV screening and education program among Korean American immigrant communities in the northeastern United States from 2009 to 2016. Through 152 outreach events, we delivered culturally and linguistically tailored education, venipuncture-based serologic testing, direct disclosure of results, and referral to care. Using prospectively collected programmatic data, we assessed reach, operational yield, and attrition across the care continuum among individuals testing positive for hepatitis B surface antigen (HBsAg), with longitudinal follow-up of up to eight years.ResultsAmong 8,453 individuals screened, 204 (2.4%) were HBsAg positive. Of these, 121 (59.3%) had longitudinal follow-up data available, and 71 (58.7%) accessed clinical care, corresponding to 34.8% of all HBsAg-positive individuals. Most participants who accessed care received follow-up through private community-based outpatient practices (64/71; 90.1%) rather than centralized systems. Approximately 42 individuals required screening to identify one case, and 104 to achieve one confirmed linkage to care. Substantial attrition occurred between diagnosis and initial clinical engagement, representing the primary loss point in the care continuum. Lack of health insurance was the most frequently reported structural barrier.ConclusionsCommunity-based HBV screening effectively identifies individuals with chronic infection but does not ensure completion of the prevention pathway. This study provides longitudinal, real-world evidence quantifying attrition across the HBV care continuum and demonstrates that prevention is an implementation-dependent process requiring sustained engagement beyond initial screening. Strategies that integrate screening with patient navigation, longitudinal follow-up, and improved access to care are needed to enhance linkage to care and clinical outcomes in high-risk populations. Background Chronic hepatitis B (CHB) remains a major cause of liver-related morbidity and mortality worldwide and disproportionately affects immigrant populations in the United States, particularly individuals originating from regions with high HBV endemicity [1–3]. Recent epidemiologic studies suggest that immigration-related demographic shifts continue to substantially influence the burden of chronic hepatitis B in the United States [3–5]. This disparity reflects epidemiologic patterns in countries of origin, where many individuals were born before the widespread implementation of universal hepatitis B vaccination programs. In these settings, vertical (perinatal) and early childhood transmission were common, resulting in a high prevalence of chronic infection that persists into adulthood. Consequently, many immigrants from high-prevalence regions enter the United States already chronically infected, in contrast to U.S.-born populations in whom vaccination and prevention of perinatal transmission have markedly reduced incidence. Additional factors, including limited prior screening and barriers to healthcare access, further compound these disparities. Despite the availability of effective vaccines, antiviral therapies, and established clinical guidelines, substantial gaps persist along the continuum from risk identification to sustained engagement in care [4–6]. These include under-recognition of at-risk individuals, incomplete screening, delayed linkage to care, and loss to follow-up. Recent studies continue to demonstrate low awareness of chronic hepatitis B infection and persistent gaps in screening and linkage-to-care among high-risk and immigrant populations in the United States [5, 6]. Structural and systemic barriers, including limited insurance coverage, language barriers, restricted access to specialty care, and low awareness of chronic hepatitis B among both patients and providers, further contribute to delayed diagnosis, inadequate monitoring, and preventable progression to advanced liver disease [4–6]. Community-based hepatitis B screening and education programs have been widely promoted to improve awareness, increase early detection, and facilitate linkage to care in high-risk immigrant communities [7–10]. However, these efforts often assume that prevention is achieved at the point of screening, when individuals at risk are identified. In practice, prevention is a longitudinal process that depends on successful navigation across multiple downstream steps, including disclosure of results, linkage to care, treatment initiation when indicated, and sustained clinical follow-up. As a result, many individuals who undergo screening do not complete the full prevention pathway, limiting the population-level effectiveness of these initiatives [11–14]. Importantly, despite continued screening efforts, persistent gaps in linkage to care and long-term engagement remain evident in high-risk populations, underscoring the need for longitudinal, real-world evaluations of prevention pathways. Prior studies, including our own, have shown that patient navigation and longitudinal engagement, delivered by bilingual program staff and trained volunteers, can improve linkage to care among individuals diagnosed with CHB [9, 10, 15]. However, fewer studies have systematically evaluated how these programs function in real-world settings, including the operational processes that determine whether screening leads to sustained care. In particular, limited attention has been given to implementation of community-based screening programs, including variation in program delivery, points of attrition along the care continuum, and structural factors such as insurance coverage, language barriers, and access to specialty care that shape these outcomes [5, 13, 16]. Implementation science frameworks provide a structured approach to evaluating how prevention programs are delivered and function in routine practice [12]. The RE-AIM framework, encompassing Reach, Effectiveness, Adoption, Implementation, and Maintenance, is widely used to assess key dimensions of program delivery, including who is reached, how interventions are implemented, and the extent to which programs are sustained over time [11, 12]. In this study, we apply the RE-AIM framework to evaluate the implementation of a long-standing community-based hepatitis B screening and education program in immigrant populations. Specifically, we examine program reach, effectiveness, adoption, implementation, and maintenance, with a focus on operational yield, attrition across the care continuum, and structural factors influencing real-world program performance. Methods Study design and setting This study is an implementation evaluation using the RE-AIM framework [11, 16] of a longstanding, community-based hepatitis B screening and education program conducted between December 2009 and March 2016 in immigrant communities across the New York, New Jersey, and Connecticut tri-state region of the northeastern United States. The intervention consisted of a recurring series of community-based outreach events designed to improve awareness, facilitate early detection, and support linkage to care among high-risk immigrant populations. The program was implemented through 152 outreach events conducted in partnership with community organizations serving predominantly Korean American populations. The majority of outreach activities occurred through faith-based and church-affiliated organizations, which accounted for 124 of the 152 outreach events. Additional outreach activities were conducted through community centers, cultural organizations, and hospital-based community health fairs. Outreach sites were selected in collaboration with community leaders to reflect diverse geographic and socioeconomic contexts, including urban, suburban, and mixed-income communities. Participants were recruited through community networks, faith-based announcements, ethnic media, and word of mouth. Participation was voluntary and open to adults present during designated screening events. No financial or material incentives were provided for participation in screening or longitudinal follow-up. At each event, bilingual program staff and trained volunteers provided culturally and linguistically tailored education on hepatitis B and offered on-site screening. Community screening and serologic testing Each outreach event integrated core program components, including culturally and linguistically tailored education, venipuncture-based on-site hepatitis B serologic testing, direct disclosure of results, and referral to primary care or specialty providers for further evaluation and management. Blood samples were collected during outreach events and transported on the same day to a commercial laboratory (e.g., Quest Diagnostics) for processing. The screening panel included hepatitis B surface antigen (HBsAg), hepatitis B surface antibody (anti-HBs IgG), and hepatitis B core antibody (anti-HBc). Educational activities included culturally and linguistically tailored counseling regarding hepatitis B transmission, chronic infection, liver disease complications, hepatocellular carcinoma risk, prevention strategies, interpretation of serologic test results, the importance of longitudinal clinical monitoring, and available treatment options. Education was delivered by physicians and trained bilingual staff through multiple formats, including printed educational brochures and handouts, PowerPoint-based community presentations, small-group educational sessions, and individualized one-on-one counseling conducted during outreach events and longitudinal follow-up interactions. Educational content emphasized the often asymptomatic nature of chronic hepatitis B, the importance of ongoing monitoring despite absence of symptoms, household transmission prevention, and the need for linkage to longitudinal medical care. Longitudinal follow-up and patient navigation Patient navigation and longitudinal engagement included bilingual telephone outreach, email communication, mailed correspondence, and direct communication during repeat community outreach events. Participants who tested positive for hepatitis B surface antigen (HBsAg) received individualized counseling regarding their results, the chronic and often asymptomatic nature of hepatitis B infection, the need for longitudinal monitoring, and potential long-term liver-related complications. Referral assistance extended beyond provision of referral letters or provider lists alone. Bilingual staff and trained volunteers actively contacted participants to encourage clinical follow-up, discussed available provider options based on participant preference and geographic accessibility, and helped facilitate connection with primary care and specialty providers. Navigation activities also included addressing participant questions and uncertainties regarding evaluation and treatment, providing additional explanation regarding laboratory findings and recommended follow-up, reducing anxiety surrounding clinical care, and encouraging continued engagement with healthcare providers over time. When available, communication and coordination with referred providers were also performed to support continuity of care and longitudinal follow-up engagement. Longitudinal follow-up data were considered available when participants could be re-contacted after screening to determine whether they had accessed clinical care following hepatitis B diagnosis. Linkage to care was defined as completion of at least one physician visit for hepatitis B evaluation following referral. During longitudinal follow-up interactions conducted by bilingual staff and trained volunteers, individuals who had not accessed clinical care were asked about the primary reasons for not pursuing medical evaluation or ongoing hepatitis B care following diagnosis. Barrier information was obtained through participant self-report during telephone outreach, email communication, and direct follow-up conversations. Reported barriers were documented in follow-up records and subsequently grouped into recurring thematic categories, including lack of health insurance, absence of symptoms, and limited disease awareness, for descriptive analysis. Participants and data sources The analytic population included all individuals identified as hepatitis B surface antigen (HBsAg) positive through the community-based screening program during the study period (n = 204), regardless of subsequent follow-up or data completeness. A subset of these individuals (n = 121) contributed longitudinal follow-up data used for effectiveness-related analyses. Data were derived from prospectively collected programmatic records obtained during outreach events, including the number of individuals screened, hepatitis B serologic test results, and documentation of education and referral activities. Baseline demographic characteristics, including age, sex, place of birth, and duration of residence in the United States, were collected when available. Different denominators were used to reflect stages of the screening and care continuum. The full screened population was used to assess program reach and operational yield, while analyses of linkage to care and longitudinal engagement were restricted to individuals with confirmed infection. This program has been described previously in outcome-focused analyses of linkage to care [15]. In contrast, the present study represents a distinct implementation evaluation that includes a broader analytic population, incorporating individuals with incomplete follow-up to enable assessment of operational yield and attrition across the care continuum. Implementation outcomes Program evaluation was guided by the RE-AIM implementation framework, which assesses Reach, Effectiveness, Adoption, Implementation, and Maintenance [11, 16]. Reach was assessed by the number and demographic characteristics of participants screened. Effectiveness was evaluated through hepatitis B detection rates and longitudinal linkage-to-care outcomes. Adoption referred to uptake of follow-up care across provider networks, including private outpatient providers such as community-based primary care and specialty practices, as well as federally qualified health centers and hospital-based clinics. Implementation assessed the operational delivery of screening, education, and navigation components across outreach settings. Maintenance evaluated the sustainability and continuity of the screening and linkage infrastructure over time. Statistical analysis Descriptive statistics were used to summarize participant demographics, hepatitis B screening outcomes, longitudinal follow-up, and linkage-to-care measures. Continuous variables are presented as means with standard deviations, and categorical variables are presented as frequencies and percentages. Exact binomial 95% confidence intervals for proportions were calculated using the Clopper–Pearson method. Analyses were primarily descriptive and focused on implementation-related outcomes across the hepatitis B screening and care continuum. Results Reach Between December 2009 and March 2016, the program conducted 152 outreach events and screened 8,453 Korean American adults age 30–79 (56.6% female; mean age, 57.1 years). The screened population consisted predominantly of first-generation Korean American immigrants residing in the New York, New Jersey, and Connecticut region; 8,075 participants (95.5%) were born in Korea. Among those screened, 204 individuals (2.4%) tested positive for hepatitis B surface antigen (HBsAg), with screening, follow-up, and linkage-to-care outcomes summarized by age group and sex in Table 1. All but three HBV-seropositive participants were born in Korea. We obtained longitudinal follow-up information for 121 individuals (59.3%). Participants with follow-up were predominantly middle-aged (mean age, 57.4 years), with the largest proportion in the 50–59 and 60–69 year age groups. Approximately 42 individuals required screening to identify one HBsAg-positive case (Table 2). Table 1Participant characteristics across the hepatitis B screening, follow-up, and linkage-to-care cascadeCharacteristicScreened (N = 8453)Positive (N = 204)Followed (N = 121)Linked (N = 71)Mean age, years (SD)57.1 (11.4)54.9 (10.7)57.4 (12.0)56.7 (11.8)Female, n (%)4479 (53.0)89 (43.6)53 (43.8)35 (49.3)Male, n (%)3974 (47.0)115 (56.4)68 (56.2)36 (50.7)Korea-born, n (%)8075 (95.5)201 (98.5)120 (99.2)71 (100)Korean-speaking, n (%)8453 (100)204 (100)121 (100)71 (100)Values are presented as mean (SD) for age and n (%) for categorical variables. Positive indicates participants who tested positive for hepatitis B surface antigen (HBsAg). Followed indicates HBsAg-positive participants with available longitudinal follow-up data. Linked indicates participants who completed at least one physician visit for hepatitis B evaluation following referral. Percentages are calculated within each column Table 1Participant characteristics across the hepatitis B screening, follow-up, and linkage-to-care cascadeCharacteristicScreened (N = 8453)Positive (N = 204)Followed (N = 121)Linked (N = 71)Mean age, years (SD)57.1 (11.4)54.9 (10.7)57.4 (12.0)56.7 (11.8)Female, n (%)4479 (53.0)89 (43.6)53 (43.8)35 (49.3)Male, n (%)3974 (47.0)115 (56.4)68 (56.2)36 (50.7)Korea-born, n (%)8075 (95.5)201 (98.5)120 (99.2)71 (100)Korean-speaking, n (%)8453 (100)204 (100)121 (100)71 (100)Values are presented as mean (SD) for age and n (%) for categorical variables. Positive indicates participants who tested positive for hepatitis B surface antigen (HBsAg). Followed indicates HBsAg-positive participants with available longitudinal follow-up data. Linked indicates participants who completed at least one physician visit for hepatitis B evaluation following referral. Percentages are calculated within each column Participant characteristics across the hepatitis B screening, follow-up, and linkage-to-care cascade Values are presented as mean (SD) for age and n (%) for categorical variables. Positive indicates participants who tested positive for hepatitis B surface antigen (HBsAg). Followed indicates HBsAg-positive participants with available longitudinal follow-up data. Linked indicates participants who completed at least one physician visit for hepatitis B evaluation following referral. Percentages are calculated within each column Table 2RE-AIM reach and operational yield of a community-based hepatitis B screening programMeasureValueOutreach events conducted152Individuals screened8,453HBsAg-positive individuals identified204Participants completing longitudinal follow-up121Mean age of follow-up cohort (years)57.4Individuals screened per HBsAg-positive case42Individuals screened per confirmed linkage to care104Operational yield metrics reflect the cumulative outreach effort required to achieve downstream clinical engagement within this community-based screening program Table 2RE-AIM reach and operational yield of a community-based hepatitis B screening programMeasureValueOutreach events conducted152Individuals screened8,453HBsAg-positive individuals identified204Participants completing longitudinal follow-up121Mean age of follow-up cohort (years)57.4Individuals screened per HBsAg-positive case42Individuals screened per confirmed linkage to care104Operational yield metrics reflect the cumulative outreach effort required to achieve downstream clinical engagement within this community-based screening program RE-AIM reach and operational yield of a community-based hepatitis B screening program Operational yield metrics reflect the cumulative outreach effort required to achieve downstream clinical engagement within this community-based screening program Effectiveness Among participants with available longitudinal follow-up information, 71 (58.7%) ultimately accessed clinical care during the follow-up period. When referenced to the full cohort of HBsAg-positive individuals, this corresponded to 34.8% achieving confirmed linkage to care (Table 3). Approximately 104 individuals required screening to achieve one confirmed linkage to care (Table 2). Table 3RE-AIM effectiveness: linkage to care and attrition across the care continuumFollow-up interval after screeningParticipants followed (n)Linked to care, n (%)< 2 years3617/36 (47.2%; 95% CI, 30.4–64.5)2–4 years2918/29 (62.1%; 95% CI, 42.3–79.3)4–6 years3023/30 (76.7%; 95% CI, 57.7–90.1)6–8 years2613/26 (50.0%; 95% CI, 29.9–70.1)Overall (followed cohort) 121 71/121 (58.7%; 95% CI, 49.4–67.5)Overall (all HBsAg-positive identified) 204 71 (34.8%) Linkage to care reflects cumulative engagement over extended follow-up. Differences between the followed cohort and the full screening cohort reflect attrition occurring between diagnosis and linkage to care Table 3RE-AIM effectiveness: linkage to care and attrition across the care continuumFollow-up interval after screeningParticipants followed (n)Linked to care, n (%)< 2 years3617/36 (47.2%; 95% CI, 30.4–64.5)2–4 years2918/29 (62.1%; 95% CI, 42.3–79.3)4–6 years3023/30 (76.7%; 95% CI, 57.7–90.1)6–8 years2613/26 (50.0%; 95% CI, 29.9–70.1)Overall (followed cohort) 121 71/121 (58.7%; 95% CI, 49.4–67.5)Overall (all HBsAg-positive identified) 204 71 (34.8%) Linkage to care reflects cumulative engagement over extended follow-up. Differences between the followed cohort and the full screening cohort reflect attrition occurring between diagnosis and linkage to care RE-AIM effectiveness: linkage to care and attrition across the care continuum Linkage to care reflects cumulative engagement over extended follow-up. Differences between the followed cohort and the full screening cohort reflect attrition occurring between diagnosis and linkage to care Although the observed linkage proportion in the 6–8 year subgroup was numerically lower than that of the 4–6 year subgroup, confidence intervals were wide and overlapped substantially, suggesting caution in interpreting this finding. The observed difference may reflect the relatively small sample size within this subgroup, incomplete long-term outcome ascertainment, participant mobility over extended follow-up periods, and evolution of the program’s navigation and longitudinal follow-up infrastructure over time. Adoption The program was implemented through partnerships with community-based organizations, including faith-based and cultural institutions, and relied on local healthcare providers for follow-up care. Among participants who accessed care (n = 71), most received care in private community-based outpatient practices (64; 90.1%), while a smaller proportion were managed in hospital-based or specialty clinics (7; 9.9%). Care was delivered across multiple community providers in the New York metropolitan and New Jersey regions. These findings indicate that follow-up care was primarily delivered through decentralized, community-based clinical networks. Implementation Core program components—including culturally and linguistically tailored education, venipuncture-based serologic screening, direct result disclosure, referral, and patient navigation—were delivered consistently across outreach events using standardized protocols and trained bilingual staff. Implementation occurred within a decentralized, community-based framework involving partnerships with organizations such as Korean Community Services and local providers. Follow-up care depended on participants accessing referred services after screening, limiting consistent linkage. Among participants who did not access care despite confirmed infection and for whom barrier data were available (n = 40), commonly reported barriers included lack of insurance (65%), absence of symptoms (22.5%), and limited disease awareness (12.5%) (Table 4). Table 4RE-AIM implementation: structural and perceived barriers to linkage to care among non-linked participants with available barrier dataPrimary barrier reportedParticipants (n = 40), n (%)Lack of health insurance26 (65.0%)Absence of symptoms9 (22.5%)Limited knowledge of hepatitis B5 (12.5%)Barriers reflect the predominant self-reported reason for not accessing care identified during longitudinal follow-up interactions Table 4RE-AIM implementation: structural and perceived barriers to linkage to care among non-linked participants with available barrier dataPrimary barrier reportedParticipants (n = 40), n (%)Lack of health insurance26 (65.0%)Absence of symptoms9 (22.5%)Limited knowledge of hepatitis B5 (12.5%)Barriers reflect the predominant self-reported reason for not accessing care identified during longitudinal follow-up interactions RE-AIM implementation: structural and perceived barriers to linkage to care among non-linked participants with available barrier data Barriers reflect the predominant self-reported reason for not accessing care identified during longitudinal follow-up interactions Discussion This study provides a longitudinal, implementation-focused evaluation of a community-based hepatitis B screening program and demonstrates that screening alone does not reliably translate into sustained engagement in care. By applying the RE-AIM framework [11, 16] across the full screened population, including individuals without complete follow-up, we identify substantial attrition across the care continuum, particularly at the transition from diagnosis to initial clinical engagement. Importantly, these challenges remain relevant in contemporary practice, as recent studies continue to demonstrate persistent gaps in linkage to care and sustained engagement despite expanded screening efforts. These findings extend prior work on community-based screening programs [7–10, 13] by shifting the focus from screening outcomes to the processes that determine whether screening leads to meaningful prevention. While community-based initiatives successfully reach high-risk populations and identify individuals with chronic hepatitis B, fewer than half of those diagnosed ultimately access care. This gap highlights the limitations of approaches that conceptualize prevention as a discrete event achieved at the point of diagnosis, rather than as a longitudinal process requiring sustained engagement. Attrition was most pronounced immediately after diagnosis, indicating that prevention pathways frequently stall at the point where individuals must transition from screening to clinical care. Of the 204 individuals identified as HBsAg positive, 83 (40.7%) were not successfully re-contacted or did not complete follow-up assessments. This pattern likely reflects a combination of structural barriers and limited perceived need for care. Lack of health insurance was the most commonly reported barrier, while absence of symptoms and limited understanding of hepatitis B as a chronic condition also contributed to non-engagement. These findings are consistent with prior studies demonstrating that patient awareness and healthcare access are critical determinants of successful linkage to care in immigrant populations [5, 13]. However, they also highlight that identification alone is insufficient without parallel systems to support navigation, follow-up, and re-engagement [8, 13]. The longitudinal design of this study provides insight into care engagement over time, which is often not captured in shorter-term or cross-sectional evaluations. From an implementation perspective, these findings underscore that successful prevention depends not only on screening reach but also on the capacity to sustain engagement over time. The operational yield observed in this study highlights the resource intensity of community-based screening programs, with substantial effort required to achieve a single confirmed linkage to care. In addition, care delivery occurred predominantly through decentralized, community-based clinical networks rather than centralized systems, suggesting that effective prevention depends on integration with local healthcare infrastructure. At the same time, evolving models of hepatitis B management and longitudinal engagement may provide additional opportunities to strengthen continuity of care within community-based prevention programs. Increasing use of telemedicine, digital outreach platforms, patient navigation systems, and remote monitoring strategies may help reduce barriers related to healthcare access, communication, and follow-up continuity among underserved populations [17, 18]. In addition, advances in HBV clinical management, including broader integration of HBV DNA monitoring and point-of-care molecular testing approaches [19], further emphasize the importance of sustained engagement beyond initial diagnosis and screening. Recent studies have demonstrated that decentralized and point-of-care HBV DNA testing platforms can substantially reduce turnaround times, facilitate more rapid progression across the HBV care cascade, and improve treatment initiation among individuals eligible for antiviral therapy. These approaches may also enhance patient engagement by providing more immediate and tangible assessment of disease activity, potentially improving risk perception and reinforcing the importance of longitudinal monitoring even among asymptomatic individuals. Furthermore, simplified and decentralized testing strategies may help address several of the barriers identified in this study, including limited healthcare access, financial constraints, and loss to follow-up associated with multi-step referral processes. Emerging fingerstick-based point-of-care HBV DNA assays may further expand accessibility by reducing reliance on conventional venipuncture, centralized laboratory infrastructure, and multiple clinical visits, thereby supporting more efficient and patient-centered longitudinal HBV care delivery in community-based and resource-limited settings [20]. Engagement often developed gradually over extended periods, indicating that short-term outcome measures may underestimate the impact of community-based interventions [14, 16]. Although linkage-to-care rates generally increased with longer duration of observation, differences in linkage proportions across follow-up intervals should be interpreted cautiously given the wide and overlapping confidence intervals. These observed differences may reflect sampling variability related to the relatively small subgroup sizes rather than true differences in long-term engagement. In addition, incomplete long-term outcome ascertainment, participant mobility over extended follow-up periods, and evolution of the program’s navigation infrastructure over time may have contributed to the observed variation. Public health implications These findings have several implications for public health practice and policy. First, community-based screening programs should not be evaluated solely on the basis of screening volume or case identification, but rather on their ability to support progression through the full care continuum. Metrics that incorporate linkage to care, retention, and longitudinal engagement provide a more accurate assessment of real-world program effectiveness [11, 12]. Second, the transition between diagnosis and initial clinical engagement represents a critical point of intervention. Strategies such as patient navigation, structured follow-up systems, and community-based care coordination may help reduce attrition at this stage [8, 13]. However, program-level interventions alone are unlikely to overcome structural barriers such as lack of insurance and limited access to care. Policies that expand healthcare access and reduce financial barriers are essential to achieving sustained population-level impact [5, 13]. Finally, these findings support a shift toward viewing hepatitis B prevention as a longitudinal, implementation-dependent process. Integrating screening with sustained engagement strategies, rather than treating screening as an endpoint, may improve outcomes in high-risk populations and enhance the effectiveness of community-based prevention programs [11, 16]. Limitations This study has several limitations. First, linkage-to-care outcomes could be assessed only among participants with available longitudinal follow-up data. A substantial proportion of individuals identified with hepatitis B infection could not be re-contacted or did not complete follow-up assessments, limiting the ability to confirm care engagement in the full cohort. In addition, the total number of individuals approached or eligible for screening was not systematically recorded, which restricts complete characterization of program reach. Second, some outcomes, including care engagement and barriers to follow-up, were based in part on self-reported data and may be subject to recall error or reporting bias. Third, although the RE-AIM framework guided the evaluation, certain domains—particularly adoption, implementation, and maintenance—were assessed using programmatic and descriptive measures rather than standardized implementation metrics, which may limit comparability with other studies. Fourth, the program was conducted primarily within Korean American communities in a single geographic region, which may limit generalizability. However, the implementation challenges identified, including attrition after diagnosis and structural barriers to care, are likely relevant to other high-risk immigrant populations and community-based settings. Finally, loss to follow-up represents both a limitation and an important finding. While incomplete follow-up restricts outcome ascertainment, it also reflects real-world challenges inherent to community-based prevention and underscores the need for systems that support longitudinal engagement and re-contact. Conclusions Community-based hepatitis B screening programs effectively identify individuals with chronic infection in high-risk immigrant populations; however, screening alone is insufficient to complete the prevention pathway. This study demonstrates that prevention is a longitudinal, implementation-dependent process in which attrition, structural barriers, and gaps in follow-up limit consistent linkage to care. By examining operational yield, attrition across the care continuum, and real-world barriers, these findings highlight the limitations of approaches that prioritize identification without adequate support for sustained engagement in care. Achieving meaningful and equitable impact will require integrating screening with structured follow-up, patient navigation, and mechanisms for re-engagement, alongside policies that improve access to care. Embedding these elements into program design is essential to translate early detection into sustained clinical care and improved long-term health outcomes in high-risk populations.